相似文献
1
Neuroblastoma: When differentiation goes awry.
Neuron. 2022 Sep 21;110(18):2916-2928. doi: 10.1016/j.neuron.2022.07.012. Epub 2022 Aug 18.
2
Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer.
Int J Mol Sci. 2021 Oct 29;22(21):11718. doi: 10.3390/ijms222111718.
3
CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
EBioMedicine. 2019 Nov;49:82-95. doi: 10.1016/j.ebiom.2019.10.041. Epub 2019 Nov 2.
4
Linking neural crest development to neuroblastoma pathology.
Development. 2022 Aug 1;149(15). doi: 10.1242/dev.200331. Epub 2022 Jul 29.
5
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Oncogene. 2013 Feb 21;32(8):1059-65. doi: 10.1038/onc.2012.106. Epub 2012 Apr 9.
6
Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
Cell Death Dis. 2017 Dec 13;8(12):3208. doi: 10.1038/s41419-017-0004-9.
7
HIF and MYC signaling in adrenal neoplasms of the neural crest: implications for pediatrics.
Front Endocrinol (Lausanne). 2023 Jun 8;14:1022192. doi: 10.3389/fendo.2023.1022192. eCollection 2023.
8
Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.
Cell Tissue Res. 2018 May;372(2):245-262. doi: 10.1007/s00441-017-2747-0. Epub 2017 Dec 8.
9
Human neuroblastoma I-type cells are malignant neural crest stem cells.
Cell Growth Differ. 1995 Apr;6(4):449-56.
10
Neural crest development and neuroblastoma: the genetic and biological link.
Prog Brain Res. 2004;146:233-42. doi: 10.1016/s0079-6123(03)46015-9.
引用本文的文献
1
Placental mesenchymal stem cell-derived interleukin-6 promotes neuroblastoma progression.
Am J Cancer Res. 2025 Aug 25;15(8):3712-3727. doi: 10.62347/KNYX4079. eCollection 2025.
2
A Small Molecule Selectively Targets N-Myc to Suppress Neuroblastoma Cancer Progression.
Int J Biol Sci. 2025 Jul 28;21(11):4895-4907. doi: 10.7150/ijbs.97195. eCollection 2025.
3
PLK4 as a Key Regulator of Neuroblastoma Differentiation and a Promising Therapeutic Target.
Int J Biol Sci. 2025 Jul 28;21(11):4979-4996. doi: 10.7150/ijbs.111449. eCollection 2025.
4
Regulation and dysregulation of microRNA - transcription factor axes in differentiation and neuroblastoma.
Cell Mol Life Sci. 2025 Aug 8;82(1):304. doi: 10.1007/s00018-025-05832-4.
5
Regulatory roles of insulin growth factor binding protein family in neuroblastoma cell proliferation and differentiation: Potential prognostic biomarkers and therapeutic targets for neuroblastoma.
Pediatr Discov. 2024 Jun 8;2(3):e68. doi: 10.1002/pdi3.68. eCollection 2024 Sep.
6
Identification of Crucial Genes Associated With MYCN-Driven Neuroblastoma Based on Single-Cell Analysis and Machine Learning.
Cancer Med. 2025 Jul;14(13):e71008. doi: 10.1002/cam4.71008.
7
Circulating tumor cells and clusters as liquid biomarkers for the diagnosis and prognosis of neuroblastoma.
BMC Cancer. 2025 Jul 1;25(1):1118. doi: 10.1186/s12885-025-14448-7.
8
How Educational Background Influences Recruitment Evaluation: Evidence from Event-Related Potentials.
Behav Sci (Basel). 2025 Jun 19;15(6):832. doi: 10.3390/bs15060832.
9
Interplay Between the Epigenome, the Microenvironment, and the Immune System in Neuroblastoma.
Cancers (Basel). 2025 May 29;17(11):1812. doi: 10.3390/cancers17111812.
10
A drug that induces the microRNA miR-124 enables differentiation of retinoic acid-resistant neuroblastoma cells.
Sci Signal. 2025 Apr 15;18(882):eads2641. doi: 10.1126/scisignal.ads2641.
本文引用的文献
1
The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma.
Dev Cell. 2022 May 23;57(10):1226-1240.e8. doi: 10.1016/j.devcel.2022.04.003. Epub 2022 Apr 27.
2
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.
J Clin Oncol. 2022 Feb 1;40(4):335-344. doi: 10.1200/JCO.21.01375. Epub 2021 Dec 6.
3
Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Cancer Res. 2022 Feb 1;82(3):484-496. doi: 10.1158/0008-5472.CAN-21-1621. Epub 2021 Dec 1.
4
Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitor.
Mol Ther Oncolytics. 2021 Sep 25;23:181-191. doi: 10.1016/j.omto.2021.09.004. eCollection 2021 Dec 17.
5
Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma.
Sci Adv. 2021 Oct 22;7(43):eabe0834. doi: 10.1126/sciadv.abe0834. Epub 2021 Oct 20.
6
Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors.
Nat Commun. 2021 Sep 7;12(1):5309. doi: 10.1038/s41467-021-24870-7.
7
Retinoblastoma from human stem cell-derived retinal organoids.
Nat Commun. 2021 Jul 27;12(1):4535. doi: 10.1038/s41467-021-24781-7.
8
Schwann cell precursors: Where they come from and where they go.
Cells Dev. 2021 Jun;166:203686. doi: 10.1016/j.cdev.2021.203686. Epub 2021 May 3.
9
Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin.
Nat Genet. 2021 May;53(5):694-706. doi: 10.1038/s41588-021-00818-x. Epub 2021 Apr 8.
10
Adrenal medulla development and medullary-cortical interactions.
Mol Cell Endocrinol. 2021 May 15;528:111258. doi: 10.1016/j.mce.2021.111258. Epub 2021 Mar 30.
Zotero 插件